These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8197103)

  • 1. [Incidence of craniopharyngioma relapses in children treated with growth hormone].
    Wilton P; Price DA
    Probl Endokrinol (Mosk); 1994; 40(2):82-5. PubMed ID: 8197103
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of craniopharyngioma.
    Shillito J
    Clin Neurosurg; 1986; 33():533-46. PubMed ID: 3791815
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
    Smith TR; Cote DJ; Jane JA; Laws ER
    J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes following treatment of childhood craniopharyngioma.
    Winkfield KM; Tsai HK; Yao X; Larson E; Neuberg D; Pomeroy SL; Ullrich NJ; Cohen LE; Kieran MW; Scott RM; Goumnerova LC; Marcus KJ
    Pediatr Blood Cancer; 2011 Jul; 56(7):1120-6. PubMed ID: 21488157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone treatment in children with craniopharyngioma with reference to the KIGS (Kabi International Growth Study) database.
    Price DA; Jönsson P
    Acta Paediatr Suppl; 1996 Oct; 417():83-5. PubMed ID: 9055921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.
    Müller HL; Gebhardt U; Schröder S; Pohl F; Kortmann RD; Faldum A; Zwiener I; Warmuth-Metz M; Pietsch T; Calaminus G; Kolb R; Wiegand C; Sörensen N;
    Horm Res Paediatr; 2010; 73(3):175-80. PubMed ID: 20197669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children.
    Takahashi H; Nakazawa S; Shimura T
    J Neurosurg; 1985 Jan; 62(1):120-7. PubMed ID: 2578064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell kinetic investigations in craniopharyngioma: preliminary results and considerations.
    Broggi G; Franzini A; Cajola L; Pluchino F
    Pediatr Neurosurg; 1994; 21 Suppl 1():21-3. PubMed ID: 7530989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of intracavitary treatment of craniopharyngioma with bleomycin.
    Broggi G; Giorgi C; Franzini A; Servello D; Solero CL
    J Neurosurg Sci; 1989; 33(1):145-8. PubMed ID: 2476533
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy with Adriamycin (doxorubicin) and CCNU (lomustine) in four children with recurrent craniopharyngioma.
    Lippens RJ; Rotteveel JJ; Otten BJ; Merx H
    Eur J Paediatr Neurol; 1998; 2(5):263-8. PubMed ID: 10726829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of treatment results in craniopharyngioma.
    Amendola BE; Gebarski SS; Bermudez AG
    J Clin Oncol; 1985 Feb; 3(2):252-8. PubMed ID: 3968554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain.
    Müller HL; Heinrich M; Bueb K; Etavard-Gorris N; Gebhardt U; Kolb R; Sörensen N
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):330-4. PubMed ID: 14520598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of craniopharyngioma in childhood.
    Matson DD; Crigler JF
    J Neurosurg; 1969 Apr; 30(4):377-90. PubMed ID: 4308176
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcome in children with recurrent craniopharyngioma after primary surgery.
    Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
    Cancer J; 2000; 6(6):388-93. PubMed ID: 11131489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radical or conservative surgery in craniopharyngioma? Importance of individualized treatment!].
    Lannering B; Westgren U
    Lakartidningen; 1995 May; 92(22):2301-5. PubMed ID: 7783489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of ectopic recurrence of craniopharyngioma. Report of 4 cases.
    Elliott RE; Moshel YA; Wisoff JH
    J Neurosurg Pediatr; 2009 Aug; 4(2):105-12. PubMed ID: 19645541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.
    Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
    Med Pediatr Oncol; 2003 Apr; 40(4):214-8. PubMed ID: 12555247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases.
    Gonc EN; Yordam N; Ozon A; Alikasifoglu A; Kandemir N
    Pediatr Neurosurg; 2004; 40(3):112-9. PubMed ID: 15367800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less is less.
    Al-Mefty O
    J Neurosurg Pediatr; 2010 Nov; 6(5):401-2; discussion 402. PubMed ID: 21039161
    [No Abstract]   [Full Text] [Related]  

  • 20. Conservative surgical approach in treatment strategy of craniopharyngioma: experience at a single institution in Italy.
    Cama A; Ravegnani M; Piatelli G; Rossi A; Gandolfo C; Garre ML
    J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():337-40. PubMed ID: 16700309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.